Gout News

SAN DIEGO — Sodium-glucose cotransporter-2 inhibition may reduce the risk for gout by as much as 40% to 60% among certain patients with type 2 diabetes treated with metformin, according to data presented at ACR Convergence 2023.

Patients who receive pegloticase alongside methotrexate for gout demonstrate higher response rates and fewer discontinuations, and were more likely to achieve tophi resolution, vs. those treated with pegloticase alone, according to data.

Amgen has reached a deal with the Federal Trade Commission that will enable the pharmaceutical company to complete its $28 billion acquisition of Horizon, according to statements from both parties.

The FDA has approved Ilaris for the treatment of gout flares in adults, marking it as the first biologic therapy to receive the nod for this indication, according to a statement from Novartis.

Clinical practice guidelines for gout disagree on when urate lowering therapy should begin and how long it should last, as well as on the use of vitamin C, pegloticase, fenofibrate and losartan, according to data published in BMC Rheumatology.

Post-menopausal women demonstrate a risk for gout that is two times that of women who have not yet reached menopause, according to a presenter at the 2023 AWIR annual conference.

The FDA has granted final approval to Zydus Lifesciences to manufacture and market generic indomethacin 50 mg suppositories, according to a company press release.

AUSTIN, Texas — Although gout is the most common, the ability to recognize, diagnose and treat other types of crystalline arthritis can make all the difference for patients, noted a speaker at the 2023 Rheumatology Nurses Society conference.

SGLT2 inhibitors were associated with a reduction in recurrent flares and gout-related ED visits among patients with type 2 diabetes and gout, according to research published in Annals of Internal Medicine.

Serum urate testing in older patients with gout does not occur as regularly as it should, based on international recommendations, in those beginning urate lowering therapy, according to data published in Arthritis Care & Research.